New hope for lung cancer patients: skipping chemo before surgery?
NCT ID NCT07231575
Summary
This study tests a chemotherapy-free combination treatment given before surgery for certain types of operable lung cancer. It aims to shrink tumors using targeted radiation, immunotherapy, and a drug that blocks tumor blood vessels, hoping to improve surgical outcomes and reduce side effects. The goal is to see if this approach is safe and effective for patients who cannot or prefer not to have traditional chemotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.